These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 31923082

  • 1. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
    Bristow RE, Chang J, Villanueva C, Ziogas A, Vieira VM.
    Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
    Pfaendler KS, Chang J, Ziogas A, Bristow RE, Penner KR.
    Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
    Bristow RE, Chang J, Ziogas A, Randall LM, Anton-Culver H.
    Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
    [Abstract] [Full Text] [Related]

  • 10. Adherence to treatment guidelines for ovarian cancer as a measure of quality care.
    Bristow RE, Chang J, Ziogas A, Anton-Culver H.
    Obstet Gynecol; 2013 Jun; 121(6):1226-1234. PubMed ID: 23812456
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA.
    J Natl Cancer Inst; 2013 Jun 05; 105(11):823-32. PubMed ID: 23539755
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN).
    Jochum F, De Rozario T, Lecointre L, Faller E, Boisrame T, Dabi Y, Lavoué V, Coutant C, Touboul C, Bolze PA, Bricou A, Canlorbe G, Collinet P, Huchon C, Bendifallah S, Ouldamer L, Mezzadri M, Querleu D, Akladios C.
    Int J Gynecol Cancer; 2021 Nov 05; 31(11):1443-1452. PubMed ID: 34607855
    [Abstract] [Full Text] [Related]

  • 19. Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.
    Chen F, Bailey CE, Alvarez RD, Shu XO, Zheng W.
    Gynecol Oncol; 2021 Jan 05; 160(1):10-15. PubMed ID: 33208254
    [Abstract] [Full Text] [Related]

  • 20. Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.
    Villanueva C, Chang J, Bartell SM, Ziogas A, Bristow R, Vieira VM.
    J Natl Compr Canc Netw; 2019 Nov 01; 17(11):1318-1329. PubMed ID: 31693984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.